COX-2 expression was upregulated in prostate luminal epithelial cells of BPH patients, and a COX-2 inhibitor reduced cell proliferation and increased apoptosis kevel in BPH rats [27,28]. This evidence concerns the gene PTGS2 and benign prostatic hyperplasia.